Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 892 results for "ranbaxy industries"

Sun Pharma-Ranbaxy Deal Cleared by Fair Trade Regulator
NDTV Profit

Sun Pharma, Ranbaxy climb after CCI clears merger deal

Sun Pharmaceutical Industries and Ranbaxy Laboratories witnessed a sharp rise in share price on Tuesday after the CCI approves merger. They have received the order of the Competition Commission of India (CCI) dated Dec. 5, 2014 (Order) by which CCI ... MyIris, 1 week ago
Sun Pharma leads the gainers list on BSE's Sensex Arihant Capital, 6 days ago
Ranbaxy Laboratories trades in green on BSE Arihant Capital, 1 week ago
[x]  

12 images for ranbaxy industries

Sify, 1 week ago
Money Today, 1 week ago
Sify, 1 week ago
Reuters, 1 week ago
Reuters, 2 weeks ago
NDTV Profit, 1 month ago
Sify, 2 weeks ago
Livemint.com, 1 month ago
NDTV Profit, 1 month ago
Sify, 1 month ago
International Business Times India

Ranbaxy Posts Loss after Write-offs on US Import Bans

Drugmaker Ranbaxy Laboratories Ltd ( RANB.NS ), which has agreed to be acquired by Sun Pharmaceutical Industries Ltd ( SUN.NS ) for $3.2 billion, posted a loss in the March quarter, hit by write-offs related to regulatory sanctions. File ...
 International Business Times India1 week ago Pharma Merger: Sun Shines in Ranbaxy Takeover Bid  International Business Times India1 week ago Sun Pharma and Ranbaxy receives CCI approval for acquisition  Equity Bulls1 week ago CCI approves Ranbaxy acquisition by Sun Pharma  HDFC Securities1 week ago
[x]  
Business Line

CCI observation to keep Sun-Ranbaxy in focus

Analysts expect the proposed merger of Sun Pharmaceutical Industries and Ranbaxy Laboratories to get green signal from the Competition Commission of India in the next few days. But they expect the watchdog may clear the deal, but will ask the companies to ...
 Business Line2 weeks ago Sun Pharma and Ranbaxy Lab will be in focus after CCI approves merger  Business Standard1 week ago Sun-Ranbaxy merger gets CCI approval, with riders  Business Standard India1 week ago CCI Approves the Proposed Merger Between Sun Pharma and Ranbaxy Subject to Modification  Noodls1 week ago
[x]  
Business Standard India

CCI rider on brand sell-off to have low impact on Sun Pharma-Ranbaxy

Antitrust regulator Competition Commission of India (CCI) on Monday gave conditional approval to Sun Pharmaceutical Industries to buy Ranbaxy Laboratories. The condition laid down by CCI is that the companies will have to divest seven products to ...
 Business Standard India1 week ago CCI rider likely to have insignificant impact on Sun Pharma-Ranbaxy  Business Standard India1 week ago
Reuters

Sun Pharma, Ranbaxy shares surge after CCI approval

Sun Pharmaceutical Industries stock gained 1.4 per cent, while shares of Ranbaxy Laboratories were up over 3 per cent on Tuesday after the Competition Commission of India (CCI) approved Sun Pharma's US $3.2 billion bid to buy Ranbaxy. Shares of ...
 Business Today India1 week ago Sun Pharma, Ranbaxy gain on CCI approval  India Infoline1 week ago Sun Pharma, Ranbaxy stocks gain on FIPB nod  Economic Times2 weeks ago Sun Pharma, Ranbaxy gain on FIPB nod  Yahoo! Maktoob News2 weeks ago
[x]  

Sun Pharma, Ranbaxy Laboratories rallies over 3% post CCI nod on deal

NEW DELHI: Sun Pharmaceutical Industries, Ranbaxy Laboratories rose over 3 per cent each in trade on Tuesday, after the Competition Commission of India approved the acquisition of generic drugmaker Ranbaxy by bigger rival Sun Pharma on the condition ...
 Economic Times1 week ago
Livemint.com

Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies

Ranbaxy, which is being acquired by larger local rival Sun Pharmaceutical Industries Ltd for $3.2 billion, has been hit by a series of regulatory sanctions in the past year due to poor production practices at its India-based plants. Photo: Pradeep ...
 Livemint.com1 month ago Pharmaceutical Newsletter - November 17 to 21, 2014  India Infoline3 weeks ago Ranbaxy, US regulator in row over revoking nods for generics  Oman Tribune4 weeks ago Ranbaxy sues USFDA  The Hindu4 weeks ago
[x]  

Here are top 10 stocks to keep an eye on November 20

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, Jindal Steel and Pennar Industries.
 Money Control4 weeks ago Top 10 stocks to keep an eye on October 29  Money Control1 month ago

Sun-Ranbaxy merger likely to get go-ahead with riders

NEW DELHI: The proposed merger of India's two leading pharmaceutical companies — Sun Pharmaceutical Industries and Ranbaxy Laboratories — is likely to get a go-ahead from the Competition Commission of India soon. However, the nod from the ...
 Times of India2 weeks ago
Livemint.com

Ranbaxy executives resign in US: reports

Report said that this move comes months after the company was acquired by Sun Pharmaceuticals Industries in April this year. Ranbaxys five top executives including country head Venkatachalam Krishnan and heads of various key departments such as finance, ...
 India Infoline2 months ago CCI suggests changes in Sun Pharma-Ranbaxy deal: Reports  India Infoline2 weeks ago CCI suggests changes to Sun-Ranbaxy deal  Livemint.com2 weeks ago Pharmaceutical Newsletter - December 01 to 05, 2014  India Infoline1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less